Timely and relevant thoracic oncology news brought to you by the only global association dedicated to the multidisciplinary study of lung cancer.

Timely and relevant thoracic oncology news brought to you by the only global association dedicated to the multidisciplinary study of lung cancer.

Youquan Li

Add ILCN as a preferred source
  • Increasing the Role of Local Consolidation in Oncogenic-Driven Advanced NSCLC

    Increasing the Role of Local Consolidation in Oncogenic-Driven Advanced NSCLC

    By

    Evolving Standards of Care

    By Youquan Li, MD, FRCR, and Andrea Bezjak, MDCM, MSc, FRCPC Posted: February 12, 2020 Targeted agents including TKIs of EGFR, ALK, and ROS1 have significantly improved the outcomes of advanced oncogene-driven NSCLC.1,2 Despite initial high response rates, durable and complete responses are rare, and most patients eventually experience treatment failure.3 Residual disease is defined…

View ILCN Archives

Provider Resources

Popular Articles

  • Interim NADIM ADJUVANT Data Suggest Adjuvant Chemo-IO May Reduce Recurrence Risk in Patients Following Complete Resection

  • Final FLAURA2 OS Data Show Osimertinib Plus Chemo Offers Benefit Compared with Monotherapy

  • Potential Impact of GLP1-RAs on TKI-induced Weight Gain in Patients with NSCLC

  • No “Known” Risk Factors: The Health Consequences of Radiation Therapy

  • Discussion Covered Updates, Strategies, and Controversies in Lung Cancer Staging

  • No PFS, OS Benefit Seen in Final Results from PACIFIC-2

  • WCLC Attendees Hear Preview of Proposed Changes for the 9th Edition of the TNM Staging Classification for Thoracic Cancers

  • Treatment of Immunotherapy-Related Dermatologic Toxicities: An Interview with Dr. Mario Lacouture

  • A Holistic Approach to Patient Care